411 related articles for article (PubMed ID: 20670937)
41. Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation.
Tsai FY; Orkin SH
Blood; 1997 May; 89(10):3636-43. PubMed ID: 9160668
[TBL] [Abstract][Full Text] [Related]
42. Direct protein interactions are responsible for Ikaros-GATA and Ikaros-Cdk9 cooperativeness in hematopoietic cells.
Bottardi S; Mavoungou L; Bourgoin V; Mashtalir N; Affar el B; Milot E
Mol Cell Biol; 2013 Aug; 33(16):3064-76. PubMed ID: 23732910
[TBL] [Abstract][Full Text] [Related]
43. The role of the GATA2 transcription factor in normal and malignant hematopoiesis.
Vicente C; Conchillo A; García-Sánchez MA; Odero MD
Crit Rev Oncol Hematol; 2012 Apr; 82(1):1-17. PubMed ID: 21605981
[TBL] [Abstract][Full Text] [Related]
44. T-cell acute leukemia 1 (TAL1) regulation of erythropoietin receptor and association with excessive erythrocytosis.
Rogers H; Wang L; Yu X; Alnaeeli M; Cui K; Zhao K; Bieker JJ; Prchal J; Huang S; Weksler B; Noguchi CT
J Biol Chem; 2012 Oct; 287(44):36720-31. PubMed ID: 22982397
[TBL] [Abstract][Full Text] [Related]
45. The order of expression of transcription factors directs hierarchical specification of hematopoietic lineages.
Iwasaki H; Mizuno S; Arinobu Y; Ozawa H; Mori Y; Shigematsu H; Takatsu K; Tenen DG; Akashi K
Genes Dev; 2006 Nov; 20(21):3010-21. PubMed ID: 17079688
[TBL] [Abstract][Full Text] [Related]
46. Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation.
Buck I; Morceau F; Cristofanon S; Heintz C; Chateauvieux S; Reuter S; Dicato M; Diederich M
Biochem Pharmacol; 2008 Nov; 76(10):1229-39. PubMed ID: 18805401
[TBL] [Abstract][Full Text] [Related]
47. Computational modeling of the hematopoietic erythroid-myeloid switch reveals insights into cooperativity, priming, and irreversibility.
Chickarmane V; Enver T; Peterson C
PLoS Comput Biol; 2009 Jan; 5(1):e1000268. PubMed ID: 19165316
[TBL] [Abstract][Full Text] [Related]
48. [Network regulation of Gata1 and Gata2 gene-dynamics underlies erythroid differentiation].
Moriguchi T; Yamamoto M
Rinsho Ketsueki; 2014 Jun; 55(6):633-42. PubMed ID: 24975332
[No Abstract] [Full Text] [Related]
49. A new twist to the GATA switch.
Philipsen S
Blood; 2013 Nov; 122(20):3391-2. PubMed ID: 24235125
[TBL] [Abstract][Full Text] [Related]
50. GATA-2 and GATA-2/ER display opposing activities in the development and differentiation of blood progenitors.
Kitajima K; Masuhara M; Era T; Enver T; Nakano T
EMBO J; 2002 Jun; 21(12):3060-9. PubMed ID: 12065419
[TBL] [Abstract][Full Text] [Related]
51. GATA-2 mediated regulation of normal hematopoietic stem/progenitor cell function, myelodysplasia and myeloid leukemia.
Rodrigues NP; Tipping AJ; Wang Z; Enver T
Int J Biochem Cell Biol; 2012 Mar; 44(3):457-60. PubMed ID: 22192845
[TBL] [Abstract][Full Text] [Related]
52. Systematic integration of GATA transcription factors and epigenomes via IDEAS paints the regulatory landscape of hematopoietic cells.
Hardison RC; Zhang Y; Keller CA; Xiang G; Heuston EF; An L; Lichtenberg J; Giardine BM; Bodine D; Mahony S; Li Q; Yue F; Weiss MJ; Blobel GA; Taylor J; Hughes J; Higgs DR; Göttgens B
IUBMB Life; 2020 Jan; 72(1):27-38. PubMed ID: 31769130
[TBL] [Abstract][Full Text] [Related]
53. Dynamics of GATA transcription factor expression during erythroid differentiation.
Leonard M; Brice M; Engel JD; Papayannopoulou T
Blood; 1993 Aug; 82(4):1071-9. PubMed ID: 8353273
[TBL] [Abstract][Full Text] [Related]
54. Mechanism governing a stem cell-generating cis-regulatory element.
Sanalkumar R; Johnson KD; Gao X; Boyer ME; Chang YI; Hewitt KJ; Zhang J; Bresnick EH
Proc Natl Acad Sci U S A; 2014 Mar; 111(12):E1091-100. PubMed ID: 24616499
[TBL] [Abstract][Full Text] [Related]
55. Gfi-1B promoter remains associated with active chromatin marks throughout erythroid differentiation of human primary progenitor cells.
Laurent B; Randrianarison-Huetz V; Kadri Z; Roméo PH; Porteu F; Duménil D
Stem Cells; 2009 Sep; 27(9):2153-62. PubMed ID: 19522008
[TBL] [Abstract][Full Text] [Related]
56. Critical Roles for PU.1, GATA1, and GATA2 in the expression of human FcεRI on mast cells: PU.1 and GATA1 transactivate FCER1A, and GATA2 transactivates FCER1A and MS4A2.
Inage E; Kasakura K; Yashiro T; Suzuki R; Baba Y; Nakano N; Hara M; Tanabe A; Oboki K; Matsumoto K; Saito H; Niyonsaba F; Ohtsuka Y; Ogawa H; Okumura K; Shimizu T; Nishiyama C
J Immunol; 2014 Apr; 192(8):3936-46. PubMed ID: 24639354
[TBL] [Abstract][Full Text] [Related]
57. Graded repression of PU.1/Sfpi1 gene transcription by GATA factors regulates hematopoietic cell fate.
Chou ST; Khandros E; Bailey LC; Nichols KE; Vakoc CR; Yao Y; Huang Z; Crispino JD; Hardison RC; Blobel GA; Weiss MJ
Blood; 2009 Jul; 114(5):983-94. PubMed ID: 19491391
[TBL] [Abstract][Full Text] [Related]
58. GATA transcription factors inhibit cytokine-dependent growth and survival of a hematopoietic cell line through the inhibition of STAT3 activity.
Ezoe S; Matsumura I; Gale K; Satoh Y; Ishikawa J; Mizuki M; Takahashi S; Minegishi N; Nakajima K; Yamamoto M; Enver T; Kanakura Y
J Biol Chem; 2005 Apr; 280(13):13163-70. PubMed ID: 15673499
[TBL] [Abstract][Full Text] [Related]
59. Gene expression profiling identifies HOXB4 as a direct downstream target of GATA-2 in human CD34+ hematopoietic cells.
Fujiwara T; Yokoyama H; Okitsu Y; Kamata M; Fukuhara N; Onishi Y; Fujimaki S; Takahashi S; Ishizawa K; Bresnick EH; Harigae H
PLoS One; 2012; 7(9):e40959. PubMed ID: 23028422
[TBL] [Abstract][Full Text] [Related]
60. HDAC1 is required for GATA-1 transcription activity, global chromatin occupancy and hematopoiesis.
Yan B; Yang J; Kim MY; Luo H; Cesari N; Yang T; Strouboulis J; Zhang J; Hardison R; Huang S; Qiu Y
Nucleic Acids Res; 2021 Sep; 49(17):9783-9798. PubMed ID: 34450641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
